Investissement Québec International

Choose Québec, a thriving environment for precision medicine Québec is a major hub for health biotech, fostering precision medicine innovation. Global leaders like Abbott, GSK, Medicago, Merck, Moderna, Novartis, and Sandoz operate here. The province offers affordable infrastructure, dedicated life sciences hubs, and low operating costs. Government support includes tax credits and investment funds. With 30,000 students in life sciences and 7,600 graduates yearly, Québec has a strong talent pool. Top universities excel in AI, bioinformatics, genomics, and immuno-oncology. The province also leads in biomarkers, diagnostics, gene therapy, and cell therapy. Cutting-edge research infrastructure strengthens its precision medicine ecosystem.